Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Trimmed by Grove Bank & Trust

Grove Bank & Trust reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 686 shares of the medical equipment provider’s stock after selling 38 shares during the quarter. Grove Bank & Trust’s holdings in Intuitive Surgical were worth $358,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Brady Martz Wealth Solutions LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $554,000. Cambridge Advisors Inc. grew its stake in Intuitive Surgical by 2.7% during the 4th quarter. Cambridge Advisors Inc. now owns 1,518 shares of the medical equipment provider’s stock worth $792,000 after buying an additional 40 shares during the last quarter. Cadinha & Co. LLC increased its position in Intuitive Surgical by 11.7% in the fourth quarter. Cadinha & Co. LLC now owns 64,943 shares of the medical equipment provider’s stock worth $33,898,000 after buying an additional 6,800 shares during the period. Clarius Group LLC lifted its stake in Intuitive Surgical by 11.8% in the fourth quarter. Clarius Group LLC now owns 2,089 shares of the medical equipment provider’s stock valued at $1,090,000 after buying an additional 220 shares during the last quarter. Finally, Oak Ridge Investments LLC boosted its holdings in shares of Intuitive Surgical by 69.2% during the fourth quarter. Oak Ridge Investments LLC now owns 17,021 shares of the medical equipment provider’s stock valued at $8,884,000 after acquiring an additional 6,961 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently weighed in on ISRG. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Truist Financial increased their price target on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Finally, Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $554.17.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 over the last quarter. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Up 1.5 %

ISRG stock opened at $592.64 on Monday. Intuitive Surgical, Inc. has a one year low of $362.14 and a one year high of $597.68. The firm has a 50-day moving average of $540.66 and a two-hundred day moving average of $499.19. The firm has a market capitalization of $211.09 billion, a PE ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.